Valuation: Abbott Laboratories

Market Cap 166B 145B 133B 124B 236B 15,822B 240B 1,603B 623B 7,777B 624B 610B 26,800B P/E 2026 *
23.6x
P/E 2027 * 20.1x
Enterprise Value 178B 155B 143B 133B 253B 16,935B 256B 1,715B 667B 8,324B 668B 653B 28,685B EV / Sales 2026 *
3.54x
EV / Sales 2027 * 3.2x
Free-Float
86.73%
Yield 2026 *
2.67%
Yield 2027 * 2.85%
1 week+3.14%
Current month+3.14%
1 month+3.57%
3 months-30.92%
6 months-30.92%
Current year-30.92%
1 week 88.14
Extreme 88.14
90.91
1 month 88.14
Extreme 88.14
91.17
Current year 82.56
Extreme 82.56
131.6
1 year 82.56
Extreme 82.56
131.6
3 years 82.56
Extreme 82.56
131.6
5 years 82.56
Extreme 82.56
131.6
10 years 82.56
Extreme 82.56
131.6
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+3.14% - - 166B
+5.04%+2.73%-5.88%-4.53% 106B
+2.80%+3.63%+0.09%+55.31% 57.69B
+1.33%+1.39%+53.16%+49.84% 53.2B
+3.39%+1.39%-10.26%-39.65% 43.56B
+3.50%+11.11% - - 36.52B
+3.47%+1.58%-14.08%-43.91% 27.49B
+0.20%+4.24%+64.56%-3.33% 25.84B
+2.78%+1.17%-8.15%-0.43% 21.27B
+1.96%+2.08%-8.43%-1.27% 20.3B
Average +2.45%+4.14%+8.87%+1.50% 43.6B
Weighted average by Cap. +2.23%+3.82%+7.58%+6.48%

Financials

2026 *2027 *
Net sales 50.26B 43.93B 40.38B 37.63B 71.38B 4,785B 72.47B 485B 188B 2,352B 189B 185B 8,105B 54.75B 47.86B 43.98B 41B 77.76B 5,213B 78.94B 528B 205B 2,562B 206B 201B 8,830B
Net income 7.02B 6.14B 5.64B 5.26B 9.97B 668B 10.12B 67.69B 26.31B 328B 26.34B 25.78B 1,132B 8.39B 7.33B 6.74B 6.28B 11.92B 799B 12.1B 80.91B 31.46B 393B 31.49B 30.81B 1,353B
Net Debt 11.69B 10.22B 9.39B 8.75B 16.6B 1,113B 16.85B 113B 43.83B 547B 43.88B 42.93B 1,885B 8.86B 7.74B 7.12B 6.63B 12.58B 843B 12.77B 85.42B 33.21B 415B 33.25B 32.53B 1,428B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change
02/07/26 USD 90.91 0.00%
01/07/26 USD 90.91 +3.14%
30/06/26 USD 88.14 0.00%
26/06/26 USD 88.14 0.00%
25/06/26 USD 88.14 0.00%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
95.40USD
Average target price
116.72USD
Spread / Average Target
+22.35%

Quarterly revenue - Rate of surprise